| Irg1/itaconate metabolic pathway is a crucial determinant of dendritic cells immune-priming function and contributes to resolute allergen-induced airway inflammation AK Jaiswal, J Yadav, S Makhija, S Mazumder, AK Mitra, A Suryawanshi, ... Mucosal immunology 15 (2), 301-313, 2022 | 42 | 2022 |
| Ligand binding turns moth pheromone-binding protein into a pH sensor UV Katre, S Mazumder, RK Prusti, S Mohanty Journal of Biological Chemistry 284 (46), 32167-32177, 2009 | 39 | 2009 |
| Structural Insights into the Ligand Binding and Releasing Mechanism of Antheraea polyphemus Pheromone-Binding Protein 1: Role of the C-Terminal Tail UV Katre, S Mazumder, S Mohanty Biochemistry 52 (6), 1037-1044, 2013 | 24 | 2013 |
| Species-specificity in myoglobin oxygenation and reduction potential properties R Nerimetla, S Krishnan, S Mazumder, S Mohanty, R Ramanathan Meat and Muscle Biology 1 (1), 1-7, 2017 | 17 | 2017 |
| Structure and Function Studies of Asian Corn Borer Ostrinia furnacalis Pheromone Binding Protein2 S Mazumder, SR Dahal, BP Chaudhary, S Mohanty Scientific Reports 8 (1), 17105, 2018 | 13 | 2018 |
| Specificity and promiscuity in human glutaminase interacting protein recognition: insight from the binding of the internal and C-terminal motif M Banerjee, DL Zoetewey, M Ovee, S Mazumder, VA Petrenko, ... Biochemistry 51 (35), 6950-6960, 2012 | 12 | 2012 |
| secDrug: a pipeline to discover novel drug combinations to kill drug-resistant multiple myeloma cells using a greedy set cover algorithm and single-cell multi-omics H Kumar, S Mazumder, S Chakravarti, N Sharma, UK Mukherjee, ... Blood cancer journal 12 (3), 39, 2022 | 10 | 2022 |
| Single-cell proteomics and tumor RNAseq identify novel pathways associated with clofazimine sensitivity in PI-and IMiD-resistant myeloma, and putative stem-like cells H Kumar, S Mazumder, N Sharma, S Chakravarti, MD Long, N Meurice, ... Frontiers in Oncology 12, 842200, 2022 | 9 | 2022 |
| Identification and characterization of key differentially expressed genes associated with metronomic dosing of topotecan in human prostate cancer T Mitra Ghosh, J White, J Davis, S Mazumder, T Kansom, E Skarupa, ... Frontiers in Pharmacology 12, 736951, 2021 | 8 | 2021 |
| Production and biophysical characterization of a mini-membrane protein, Ost4V23D: A functionally important mutant of yeast oligosaccharyltransferase subunit Ost4p B Chaudhary, S Mazumder, S Mohanty Protein Expression and Purification 139, 43-48, 2017 | 8 | 2017 |
| Integrating pharmacogenomics data-driven computational drug prediction with single-cell RNAseq to demonstrate the efficacy of a NAMPT inhibitor against aggressive, taxane … S Mazumder, T Mitra Ghosh, UK Mukherjee, S Chakravarti, F Amiri, ... Cancers 14 (23), 6009, 2022 | 6 | 2022 |
| The andrographolide analogue 3A. 1 synergizes with taxane derivatives in aggressive metastatic prostate cancers by upregulation of heat shock proteins and downregulation of … TM Ghosh, T Kansom, S Mazumder, J Davis, AS Alnaim, SL Jasper, ... Journal of Pharmacology and Experimental Therapeutics 380 (3), 180-201, 2022 | 5 | 2022 |
| Structural and Functional Characterization of European Corn Borer, Ostrinia nubilalis, Pheromone Binding Protein 3 O Al-Danoon, S Mazumder, BP Chaudhary, V Nukala, B Bishop, ... Journal of agricultural and food chemistry 69 (46), 14013-14023, 2021 | 4 | 2021 |
| Pheromone Perception: Mechanism of the Reversible Coil–Helix Transition in Antheraea polyphemus Pheromone-Binding Protein 1 S Mazumder, BP Chaudhary, SR Dahal, O Al-Danoon, S Mohanty Biochemistry 58 (45), 4530-4542, 2019 | 4 | 2019 |
| Metronomic Administration of Topotecan Alone and in Combination with Docetaxel Inhibits Epithelial–mesenchymal Transition in Aggressive Variant Prostate Cancers T Mitra Ghosh, S Mazumder, J Davis, J Yadav, A Akinpelu, A Alnaim, ... Cancer Research Communications 3 (7), 1286-1311, 2023 | 3 | 2023 |
| Sample average treatment effect on the treated (SATT) analysis using counterfactual explanation identifies BMT and SARS-CoV-2 vaccination as protective risk factors associated … AK Mitra, UK Mukherjee, S Mazumder, V Madhira, T Bergquist, YR Shao, ... Blood cancer journal 13 (1), 180, 2023 | 2 | 2023 |
| Extended Exposure Topotecan Significantly Improves Long-Term Drug Sensitivity by Decreasing Malignant Cell Heterogeneity and by Preventing Epithelial–Mesenchymal Transition JT Davis, TM Ghosh, S Mazumder, A Mitra, RC Bird, RD Arnold International Journal of Molecular Sciences 24 (10), 8490, 2023 | 2 | 2023 |
| 46 Species-specificity in metmyoglobin reduction E Bechtold, S Suman, S Mohanty, S Mazumder, S Krishnan, R Nerimetla Journal of Animal Science 97 (Supplement_1), 83-84, 2019 | 2 | 2019 |
| Integrating pharmacogenomics data-driven prediction with bulk and single-cell RNAseq to demonstrate the efficacy of an NAMPT inhibitor against aggressive, taxane-resistant, and … S Mazumder, TM Ghosh, UK Mukherjee, S Chakravarti, F Amiri, ... bioRxiv, 2022.07. 20.500378, 2022 | 1 | 2022 |
| Deciphering the functional basis of synergy between taxanes and TAK715: A novel repurposed drug candidate in treatment-refractory aggressive prostate cancer S Chakravarti, S Mazumder, F Hemmati, F Amiri, TM Ghosh, ... Cancer Research 81 (13_Supplement), 1354-1354, 2021 | 1 | 2021 |
